{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T01:36:48Z","timestamp":1715996208016},"reference-count":20,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.neulet.2005.01.044","type":"journal-article","created":{"date-parts":[[2005,2,11]],"date-time":"2005-02-11T09:15:45Z","timestamp":1108113345000},"page":"176-180","source":"Crossref","is-referenced-by-count":6,"title":["Budesonide epimer R, LAU-8080 and phenyl butyl nitrone synergistically repress cyclooxygenase-2 induction in [IL-1\u03b2+A\u03b242]-stressed human neural cells"],"prefix":"10.1016","volume":"380","author":[{"given":"Merete","family":"Boedker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Boetkjaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas G.","family":"Bazan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Guo","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo Palacios","family":"Pelaez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter J.","family":"Lukiw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2005.01.044_bib1","doi-asserted-by":"crossref","first-page":"30359","DOI":"10.1074\/jbc.M203201200","article-title":"Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells","volume":"277","author":"Bazan","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2005.01.044_bib2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1749-6632.1998.tb09924.x","article-title":"Structural and functional changes in proteins induced by free radical-mediated oxidative stress and protective action of the antioxidants N-tert-butyl-alpha-phenylnitrone and Vitamin E","volume":"854","author":"Butterfield","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neulet.2005.01.044_bib3","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/art.20374","article-title":"Therapeutic cocktails for rheumatoid arthritis","volume":"50","author":"Cronstein","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.neulet.2005.01.044_bib4","first-page":"70","article-title":"Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 alpha, 17 alpha-acetal-substituted glucocorticoids","volume":"25","author":"Dahlberg","year":"1984","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neulet.2005.01.044_bib5","doi-asserted-by":"crossref","first-page":"21237","DOI":"10.1074\/jbc.M110955200","article-title":"Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism","volume":"277","author":"Deo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2005.01.044_bib6","first-page":"31","article-title":"Experimental brain inflammation and neurodegeneration as model of Alzheimer's disease: protective effects of selective COX-2 inhibitors","volume":"16","author":"Giovannini","year":"2003","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.neulet.2005.01.044_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/exnr.2001.7754","article-title":"Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse","volume":"173","author":"Gordon","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neulet.2005.01.044_bib8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2174\/1389450033490902","article-title":"Non-steroidal anti-inflammatory drugs and cyclooxygenase in Alzheimer's disease","volume":"4","author":"Hoozemans","year":"2003","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.neulet.2005.01.044_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.brainres.2004.01.074","article-title":"alpha-Phenyl-n-tert-butyl-nitrone attenuates hypoxic-ischemic white matter injury in the neonatal rat brain","volume":"1007","author":"Lin","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2005.01.044_bib10","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1023\/B:NERE.0000023615.89699.63","article-title":"Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling","volume":"29","author":"Lukiw","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neulet.2005.01.044_bib11","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1073\/pnas.95.7.3914","article-title":"Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1beta-induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes","volume":"95","author":"Lukiw","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neulet.2005.01.044_bib12","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.4049\/jimmunol.169.11.6474","article-title":"Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor","volume":"169","author":"Marrache","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.neulet.2005.01.044_bib13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0278-5846(03)00124-6","article-title":"Inflammatory processes in Alzheimer's disease","volume":"27","author":"McGeer","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2005.01.044_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000067428","article-title":"Cyclooxygenase as a target for the antiamyloidogenic activities of nonsteroidal anti-inflammatory drugs in Alzheimer's disease","volume":"11","author":"Pasinetti","year":"2002","journal-title":"Neurosignals"},{"key":"10.1016\/j.neulet.2005.01.044_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/WNL.62.1.66","article-title":"Rofecoxib Protocol 091 Study Group, Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study","volume":"62","author":"Reines","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2005.01.044_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1124\/dmd.32.1.113","article-title":"Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of active metabolites","volume":"32","author":"Remmel","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neulet.2005.01.044_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-1-21","article-title":"Brain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosis","volume":"1","author":"Yao","year":"2004","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.neulet.2005.01.044_bib18","first-page":"81","article-title":"Neuroprotection in brain ischemia","volume":"57","author":"Zador","year":"2004","journal-title":"Ideggyogy Sz."},{"key":"10.1016\/j.neulet.2005.01.044_bib19","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1023\/B:PHAM.0000033015.84146.4c","article-title":"Combined effects of multiple flavinoids on breast cancer resistance protein (ABCG2)-mediated transport","volume":"21","author":"Zhang","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neulet.2005.01.044_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/0091270003261333","article-title":"Cocktail approaches and strategies in drug development","volume":"44","author":"Zhou","year":"2004","journal-title":"J. Clin. Pharmacol."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394005000716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394005000716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T13:50:28Z","timestamp":1548683428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394005000716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":20,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0304394005000716"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2005.01.044","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}